Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagers

Sheena Pinto1, Jens Pahl1, Arndt Schottelius1

  • 1Affimed GmbH, Heidelberg, Germany.

Trends in Immunology
|October 28, 2022
PubMed

Insights

Multispecific antibodies enhance cancer immunotherapy by directing immune cells to target cancer cells. Novel antibody engineering aims to improve efficacy, especially for solid tumors, by maximizing natural killer (NK) cell potential.

Area of Science:

  • Immunology and Cancer Therapy
  • Antibody Engineering for Targeted Therapies

Background:

  • Multispecific antibodies redirect immune effector cells (NK cells, macrophages, neutrophils) to eliminate cancer cells.
  • Current successes are notable in hematological malignancies, but challenges persist for solid tumors.
  • Limitations include increasing efficacy, overcoming dose-limiting toxicities, and managing immunogenicity.

Purpose of the Study:

  • To discuss novel antibody-engineering strategies.
  • To focus on maximizing the potential of natural killer (NK) cells in cancer immunotherapy.
  • To expand therapeutic options using NK cell engagers.

Main Methods:

  • Review of antibody-engineering developments.
  • Focus on NK cell engagers.
  • Exploration of antibody-dependent cellular cytotoxicity (ADCC) mechanisms.

Main Results:

  • Novel engineering approaches are being developed.
  • Strategies aim to enhance NK cell-mediated anti-tumor activity.
  • Potential for improved therapeutic outcomes in cancer patients.

Conclusions:

  • Advanced antibody engineering can overcome current immunotherapy limitations.
  • Maximizing NK cell engagement is a promising strategy for broader cancer treatment.
  • These developments expand the toolkit for effective cancer immunotherapy.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
2.0K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.6K